The University of Washington School of Law, the End of Life Liberty Project, and the Drug Policy Alliance present Psychedelic Medicine: New Frontiers in Palliative Care Oct. 27, 2017, at UW Law.
Exciting new research is revealing that psychedelic drugs, such as psilocybin and MDMA, may offer significant benefit for patients struggling at the end of life and those beset by major depressions and treatment-resistant post-traumatic stress.
This conference brings together doctors, scientific researchers, attorneys and ethicists to consider the medical, legal and ethical implications of this evolving research.
